USD 1.31
(9.17%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 78.16 Million USD | -43.07% |
2022 | 137.28 Million USD | 18.86% |
2021 | 115.49 Million USD | 51.69% |
2020 | 76.14 Million USD | -36.26% |
2019 | 119.45 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 46.3 Million USD | -18.44% |
2024 Q1 | 56.77 Million USD | -27.36% |
2023 FY | 78.16 Million USD | -43.07% |
2023 Q3 | 88.32 Million USD | -15.18% |
2023 Q2 | 104.13 Million USD | -15.96% |
2023 Q1 | 123.91 Million USD | -9.74% |
2023 Q4 | 78.16 Million USD | -11.51% |
2022 Q3 | 142.94 Million USD | 62.6% |
2022 Q2 | 87.9 Million USD | -11.09% |
2022 Q1 | 98.87 Million USD | -14.39% |
2022 FY | 137.28 Million USD | 18.86% |
2022 Q4 | 137.28 Million USD | -3.96% |
2021 Q4 | 115.49 Million USD | 166.03% |
2021 FY | 115.49 Million USD | 51.69% |
2021 Q3 | 43.41 Million USD | -17.3% |
2021 Q2 | 52.49 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 76.14 Million USD | -36.26% |
2020 Q4 | 76.14 Million USD | 0.0% |
2019 FY | 119.45 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.893% |
Allurion Technologies Inc. | 71.71 Million USD | -8.992% |
Artivion, Inc. | 792.39 Million USD | 90.136% |
Avanos Medical, Inc. | 1.69 Billion USD | 95.382% |
Butterfly Network, Inc. | 304.27 Million USD | 74.313% |
Butterfly Network, Inc. | 304.27 Million USD | 74.313% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 99.365% |
Boston Scientific Corporation | 35.13 Billion USD | 99.778% |
CONMED Corporation | 2.3 Billion USD | 96.602% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 99.165% |
Paragon 28, Inc. | 340.69 Million USD | 77.059% |
Glaukos Corporation | 940.41 Million USD | 91.689% |
Globus Medical, Inc. | 5.08 Billion USD | 98.463% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 88.452% |
Integer Holdings Corporation | 2.94 Billion USD | 97.344% |
Medtronic plc | 89.98 Billion USD | 99.913% |
Myomo, Inc. | 14.58 Million USD | -436.019% |
Nevro Corp. | 635.71 Million USD | 87.705% |
Owlet, Inc. | 44.12 Million USD | -77.141% |
Penumbra, Inc. | 1.55 Billion USD | 94.978% |
Vicarious Surgical Inc. | 119.86 Million USD | 34.793% |
Smith & Nephew plc | 9.98 Billion USD | 99.217% |
STERIS plc | 11.06 Billion USD | 99.294% |
Stryker Corporation | 39.91 Billion USD | 99.804% |
Vapotherm, Inc. | 77.61 Million USD | -0.7% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 99.636% |